Artykuły udostępnione publicznie: - Steven HillWięcej informacji
Niedostępne w żadnym miejscu: 6
Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer
SM Hill, DE Blask, S Xiang, L Yuan, L Mao, RT Dauchy, EM Dauchy, ...
Journal of mammary gland biology and neoplasia 16, 235-245, 2011
Upoważnienia: US National Institutes of Health
Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines
L Lai, L Yuan, Q Cheng, C Dong, L Mao, SM Hill
Breast cancer research and treatment 118, 293-305, 2009
Upoważnienia: US National Institutes of Health
Melatonin inhibits mitogenic cross-talk between retinoic acid-related orphan receptor alpha (RORα) and ERα in MCF-7 human breast cancer cells
C Dong, L Yuan, J Dai, L Lai, L Mao, S Xiang, B Rowan, SM Hill
Steroids 75 (12), 944-951, 2010
Upoważnienia: US National Institutes of Health
Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin
SM Hill, C Cheng, L Yuan, L Mao, R Jockers, B Dauchy, T Frasch, ...
Breast cancer research and treatment 127, 91-98, 2011
Upoważnienia: US National Institutes of Health
A method for growing tissue-isolated human tumor xenografts in nude rats for melatonin/cancer studies
RT Dauchy, SM Hill, DE Blask
Melatonin: Methods and Protocols, 489-496, 2022
Upoważnienia: US National Institutes of Health
A Method for Perfusion of Tissue-Isolated Human Tumor Xenografts in Nude Rats to Investigate the Oncostatic Role of the Physiological Nocturnal Melatonin Signal
RT Dauchy, SM Hill, DE Blask
Melatonin: Methods and Protocols, 477-488, 2022
Upoważnienia: US National Institutes of Health
Dostępne w jakimś miejscu: 39
Melatonin: an inhibitor of breast cancer
SM Hill, VP Belancio, RT Dauchy, S Xiang, S Brimer, L Mao, A Hauch, ...
Endocrine-related cancer 22 (3), R183-R204, 2015
Upoważnienia: US National Institutes of Health
Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its …
DE Blask, SM Hill, RT Dauchy, S Xiang, L Yuan, T Duplessis, L Mao, ...
Journal of pineal research 51 (3), 259-269, 2011
Upoważnienia: US National Institutes of Health
Molecular mechanisms of melatonin anticancer effects
SM Hill, T Frasch, S Xiang, L Yuan, T Duplessis, L Mao
Integrative cancer therapies 8 (4), 337-346, 2009
Upoważnienia: US National Institutes of Health
Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway
L Mao, L Yuan, LM Slakey, FE Jones, ME Burow, SM Hill
Breast Cancer Research 12, 1-14, 2010
Upoważnienia: US National Institutes of Health
Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer
RT Dauchy, S Xiang, L Mao, S Brimer, MA Wren, L Yuan, M Anbalagan, ...
Cancer research 74 (15), 4099-4110, 2014
Upoważnienia: US National Institutes of Health
Light exposure at night disrupts host/cancer circadian regulatory dynamics: impact on the Warburg effect, lipid signaling and tumor growth prevention
DE Blask, RT Dauchy, EM Dauchy, L Mao, SM Hill, MW Greene, ...
PLoS One 9 (8), e102776, 2014
Upoważnienia: US National Institutes of Health
Doxorubicin resistance in breast cancer is driven by light at night‐induced disruption of the circadian melatonin signal
S Xiang, RT Dauchy, A Hauch, L Mao, L Yuan, MA Wren, VP Belancio, ...
Journal of pineal research 59 (1), 60-69, 2015
Upoważnienia: US National Institutes of Health
Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models
Q Zhang, S Liu, D Ge, Q Zhang, Y Xue, Z Xiong, AB Abdel-Mageed, ...
Cancer research 72 (10), 2589-2599, 2012
Upoważnienia: US National Institutes of Health
Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β
L Mao, RT Dauchy, DE Blask, LM Slakey, S Xiang, L Yuan, EM Dauchy, ...
Molecular Endocrinology 26 (11), 1808-1820, 2012
Upoważnienia: US National Institutes of Health
Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer
Y Qi, X Fu, Z Xiong, H Zhang, SM Hill, BG Rowan, Y Dong
PloS one 7 (2), e31539, 2012
Upoważnienia: US National Institutes of Health
Phosphorylation of estrogen receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription
TT Duplessis, CC Williams, SM Hill, BG Rowan
Endocrinology 152 (6), 2517-2526, 2011
Upoważnienia: US National Institutes of Health
Epigenetic inhibition of the tumor suppressor ARHI by light at night‐induced circadian melatonin disruption mediates STAT3‐driven paclitaxel resistance in breast cancer
S Xiang, RT Dauchy, AE Hoffman, D Pointer, T Frasch, DE Blask, SM Hill
Journal of pineal research 67 (2), e12586, 2019
Upoważnienia: US National Institutes of Health
Oscillation of clock and clock controlled genes induced by serum shock in human breast epithelial and breast cancer cells: regulation by melatonin
S Xiang, L Mao, T Duplessis, L Yuan, R Dauchy, E Dauchy, DE Blask, ...
Breast Cancer: Basic and Clinical Research 6, BCBCR. S9673, 2012
Upoważnienia: US National Institutes of Health
Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression
L Mao, W Summers, S Xiang, L Yuan, RT Dauchy, A Reynolds, ...
Molecular Cancer Research 14 (11), 1159-1169, 2016
Upoważnienia: US National Institutes of Health
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy